This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1978 Aug;62(8):1199-200.

Phase II study of dianhydrogalactitol in malignant glioma

P Espana, P H Wiernik, M D Walker

PMID: 210944

Clinical Trial

Phase II study of dianhydrogalactitol in malignant glioma

P Espana et al. Cancer Treat Rep. 1978 Aug.

. 1978 Aug;62(8):1199-200.

Authors

P Espana, P H Wiernik, M D Walker

PMID: 210944

No abstract available

PubMed Disclaimer

Similar articles

Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
Finklestein JZ, Shore N, Krivit W, Hammond D, Higgins G. Finklestein JZ, et al. Cancer Treat Rep. 1985 Nov;69(11):1331-3. Cancer Treat Rep. 1985. PMID: 4092198 No abstract available.
Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
Eagan RT, Childs DS Jr, Layton DD Jr, Laws ER Jr, Bisel HF, Holbrook MA, Fleming TR. Eagan RT, et al. JAMA. 1979 May 11;241(19):2046-50. JAMA. 1979. PMID: 219269 Clinical Trial.
Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
Haas CD, Baker L, Thigpen T. Haas CD, et al. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):115-7. Cancer Treat Rep. 1981. PMID: 6261943
Clinical trials with the hexitol derivatives in the U.S.
Chiuten DF, Rozencweig M, Von Hoff DD, Muggia FM. Chiuten DF, et al. Cancer. 1981 Feb 1;47(3):442-51. doi: 10.1002/1097-0142(19810201)47:3<442::aid-cncr2820470304>3.0.co;2-1. Cancer. 1981. PMID: 6784907 Review.
Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M. Kortmann RD, et al. Strahlenther Onkol. 2003 Apr;179(4):219-32. doi: 10.1007/s00066-003-1027-y. Strahlenther Onkol. 2003. PMID: 12707711 Review.

See all similar articles

Cited by

In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol.
Rubin NH, Casartelli C, Macik BG, Boerwinkle WR, Barranco SC. Rubin NH, et al. Invest New Drugs. 1983;1(2):129-37. doi: 10.1007/BF00172071. Invest New Drugs. 1983. PMID: 6678862
1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G₂/M phase.
Peng C, Qi XM, Miao LL, Ren J. Peng C, et al. Acta Pharmacol Sin. 2017 Apr;38(4):561-570. doi: 10.1038/aps.2016.154. Epub 2017 Feb 20. Acta Pharmacol Sin. 2017. PMID: 28216618 Free PMC article.
Effect of a single high dose and repeated small doses of dianhydrogalactitol (DAG; NSC-132313) on rat intestinal mucosa.
Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Szentirmay Z. Kralovánszky J, et al. Cancer Chemother Pharmacol. 1983;11(3):167-71. doi: 10.1007/BF00254198. Cancer Chemother Pharmacol. 1983. PMID: 6416695
Heuristic modeling of drug delivery to malignant brain tumors.
Levin VA, Patlak CS, Landahl HD. Levin VA, et al. J Pharmacokinet Biopharm. 1980 Jun;8(3):257-96. doi: 10.1007/BF01059646. J Pharmacokinet Biopharm. 1980. PMID: 7420270
Combined treatment of anaplastic astrocytoma (grade 3-4) with diacetyl-dianhydro-galactitol (DADAG).
Afra D, Kerpel-Fronius S, Szinai I, Kocsis B, Eckhardt S. Afra D, et al. J Neurooncol. 1990 Feb;8(1):85-91. doi: 10.1007/BF00182091. J Neurooncol. 1990. PMID: 2319295

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database